Trial · NCT01607320
Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome
NCT01607320, Not applicable, Terminated, Bruce Lessey; results first posted 2015-06-01
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome. Trials, record NCT01607320. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01607320
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome
- NCT number
- NCT01607320
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 3 participants, actual
- Lead sponsor
- Bruce Lessey
- Conditions
- Polycystic Ovarian Syndrome
- Interventions
- Raloxifene, Clomiphene
- First posted
- 2012-05-30
- Last updated
- 2018-09-20
- Results first posted
- 2015-06-01
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pregnancy | 4 months | Time frame will vary depending on how many treatment cycles it takes to get pregnant. If no pregnancy occurs, study participation will likely be about 4 months. |
| Secondary | Ovulation | Cycle day 22-24 | If ovulation does not occur during the first treatment cycle, subject will be withdrawn from study. |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Pregnancy | 4 months | The study was randomized between the two treatments and was never unblinded, therefore randomization is unknown and data collection is incomplete. | ||
| SECONDARY | Ovulation | Cycle day 22-24 | Data collected could not be analyzed as it was never unblended and randomization is unknown. |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Raloxifene | 0 | |
| Overall Study | STARTED | Clomiphene | 0 | |
| Overall Study | COMPLETED | Raloxifene | 0 | |
| Overall Study | COMPLETED | Clomiphene | 0 | |
| Overall Study | NOT COMPLETED | Raloxifene | 0 | |
| Overall Study | NOT COMPLETED | Clomiphene | 0 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | headache | General disorders | All Study Participants | 1 | 3 | |
| other | head cold | Infections and infestations | All Study Participants | 1 | 3 |
Source ClinicalTrials.gov
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | All Study Participants | ||
| Total, other adverse events | All Study Participants | 2 | 3 |
| Total, serious adverse events | All Study Participants | 0 | 3 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01607320
GET https://conductscience.org/api/trials/v1/NCT01607320/registered